Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7494033
Reference Type
Journal Article
Title
Influence of Derivatisation of the Hydroxy Groups in 1,1âBisâ(4âhydroxyphenyl)â2âphenylbutâ1âene on Estradiol Receptor Affinity and Mammary Tumor Inhibiting Properties
Author(s)
Schuderer, ML; Schneider, MR
Year
1987
Is Peer Reviewed?
Yes
Journal
Archiv der Pharmazie
ISSN:
0365-6233
EISSN:
1521-4184
Volume
320
Issue
7
Page Numbers
635-641
Language
English
DOI
10.1002/ardp.19873200713
Abstract
The phenolic hydroxy groups of 1,1âbisâ(4âhydroxyphenyl)â2âphenylbutâ1âene (1) were converted to esters of different chain length and degree of halogen substitution, and to carbamate, imidoester and ether derivatives. Most of the products maintain the affinity to the estrogen receptor. The acetate 2 has a better antitumor potency than 1. Copyright © 1987 WILEYâVCH Verlag GmbH & Co. KGaA, Weinheim
Keywords
1,1 bis(4 acetoxyphenyl) 2 phenyl 1 butene; 1,1 bis(4 hydroxyphenyl) 2 phenyl 1 butene; 1,1 bis(4 hydroxyphenyl) 2 phenyl 1 butene derivative; estradiol h 3; unclassified drug; animal cell; animal experiment; animal model; breast; cancer chemotherapy; cattle; drug comparison; drug efficacy; drug receptor binding; drug stability; drug structure; drug synthesis; female genital system; mouse; nonhuman; nuclear magnetic resonance; structure activity relation; subcutaneous drug administration; therapy; Animal; Antineoplastic Agents; Cattle; Chemistry; Estradiol; Female; In Vitro; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Receptors, Estrogen; Stilbenes; Support, Non-U.S. Gov't
Tags
Other
•
Harmful Algal Blooms- Health Effects
April 2021 Literature Search
Scopus
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity